27th July 2018, Volume 131 Number 1479

Once-daily single-inhaler triple versus dual therapy in patients with COPD Triple inhaled therapy for chronic obstructive pulmonary disease (COPD) comprises an inhaled glucocorticoid, a long-acting muscarinic antagonist (LAMA), and a…

Subscriber content

The full contents of this page is only available to subscribers.

To view this content please login or subscribe

Download

The downloadable PDF version of this article is only available to subscribers.

To view this content please login or subscribe